Healthpeak Properties, Inc. $DOC Holdings Boosted by Barclays PLC

Barclays PLC boosted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 7.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,495,525 shares of the real estate investment trust’s stock after purchasing an additional 97,662 shares during the quarter. Barclays PLC owned approximately 0.22% of Healthpeak Properties worth $28,639,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in DOC. State Street Corp grew its holdings in Healthpeak Properties by 0.9% in the 2nd quarter. State Street Corp now owns 48,602,649 shares of the real estate investment trust’s stock worth $851,032,000 after buying an additional 442,481 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after purchasing an additional 8,212,504 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Healthpeak Properties by 1.0% in the second quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust’s stock worth $332,625,000 after purchasing an additional 197,540 shares during the period. Charles Schwab Investment Management Inc. grew its position in Healthpeak Properties by 2.8% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust’s stock valued at $184,208,000 after buying an additional 282,155 shares in the last quarter. Finally, Cullen Capital Management LLC increased its stake in Healthpeak Properties by 6.7% during the 3rd quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock valued at $195,960,000 after buying an additional 641,771 shares during the period. 93.57% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on DOC. Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. The Goldman Sachs Group assumed coverage on shares of Healthpeak Properties in a report on Friday, January 9th. They issued a “neutral” rating and a $17.00 target price on the stock. Weiss Ratings upgraded shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 26th. Wells Fargo & Company restated a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. Finally, Cantor Fitzgerald set a $17.00 price objective on Healthpeak Properties in a research report on Monday, January 5th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $19.42.

Healthpeak Properties Stock Performance

Shares of DOC opened at $17.08 on Thursday. The company has a market capitalization of $11.87 billion, a PE ratio of 170.77, a PEG ratio of 9.31 and a beta of 1.12. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. The company’s 50 day moving average price is $17.16 and its 200 day moving average price is $17.58. Healthpeak Properties, Inc. has a 52 week low of $15.71 and a 52 week high of $20.81.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. During the same period in the prior year, the firm posted $0.46 EPS. The business’s revenue was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) dividend on an annualized basis and a dividend yield of 7.1%. Healthpeak Properties’s payout ratio is 1,220.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.